510(k) K231370
K231370 is an FDA 510(k) premarket notification submitted by Donnevie Medical Technology (Shanghai) Co. , Ltd. for the device "Dewin Blastocyst Medium (with HSA and without HSA)". The FDA issued a decision of Substantially Equivalent on August 4, 2023. The device falls under product code MQL (Media, Reproductive), a Class II device regulated under 21 CFR 884.6180. Donnevie Medical Technology (Shanghai) Co. , Ltd. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 4, 2023
- Date Received
- May 12, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Media, Reproductive
- Device Class
- Class II
- Regulation Number
- 884.6180
- Review Panel
- OB
- Submission Type